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Purpose: To study the effect of different inhibitors on the fibrinolytic activity of the enzyme produced by 
Ganoderma lucidum.   
Method: The intracellular fibrinolytic protease produced by Ganoderma lucidum VK12 was isolated from 
the mycelia grown in MCDBF broth and was purified to homogeneity using ammonium sulfate 
fractionation, ion exchange chromatography and sephadex G-150 column chromatography techniques. 
The purity of the enzyme was verified on SDS-PAGE after silver nitrate staining. The inhibitory effect of 
different metal ions and commercial protease inhibitors on enzyme activity was studied. The inhibitor-
treated enzyme was assayed with its substrate and the residual activity of the enzyme recorded.  
Result: The fibrinolytic enzyme isolated from Ganoderma lucidum was purified to near homogeneity and 




 inhibited the 
activity of the enzyme while Zn
2+ 
ions enhanced the activity. . Complete inactivation occurred when the 
enzyme was incubated with protease inhibitors such as EDTA, 1, 10-phenanthroline, phosphoamidon 
while the enzyme was insensitive to protease inhibitors such as leupeptin, PMSF, TPCK and APMSF. 
Conclusion: Copper sulfate completely inhibited the enzyme activity. The sensitivity of this enzyme to 
EDTA suggests that it might be a metalloprotease.  
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INTRODUCTION 
 
Blood clots are formed from fibrinogen by 
thrombin (EC 3.4.21.5) and are lysed by 
plasmin (EC 3.4.21.7), which is activated 
from plasminogen by tissue plasminogen 
activator (tPA). Although fibrin clot formation 
and fibrinolysis are maintained in balance by 
the biological system, thromboses such as 
myocardial infarction, occur when clots are 
not lysed as a result of a disorder in the 
balance. Intravenous administration of 
urokinase and streptokinase was widely used 
for thrombosis therapy but these enzymes 
have low specificity for fibrin. tPA was 
developed for the treatment of thrombosis 
because of its efficiency and strong affinity for 
fibrin [1]. However, these enzymes are 
expensive, and patients may suffer from 
undesirable side effects such as 
gastrointestinal bleeding and allergic reaction 
[2]. Therefore, this necessitated the search 
for thrombolytic agents from other biological 
sources. Recently, fibrinolytic enzymes have 
been discovered in fermented food products 
such as Japanese natto [3], Korean Chang 
kook-Jang soy sauce [4] and fermented 
shrimp paste [5].  
 
In the East Asian countries, the species of 
Ganoderma are regarded as the herb of 
longevity and have been used in folk 
medicine for hundreds of years. Some strains 
have been cultivated commercially for the 
preparation of health tablets [6]. Medicinal 
benefits of Ganoderma spp. have been 
reviewed by Jong and Birmongham [7]. Choi 
and Sa [8] have reported the presence of 
fibrinolytic enzyme from a Chinese isolate of 
Ganoderma lucidum. In the present study, 
different Ganoderma lucidum isolates 
collected from several locations in southern 
India were screened for the presence of 
fibrinolytic protease enzyme. A strain, VK12, 
isolated from Tamarindus indica which 
showed the highest fibrinolytic protease 
activity, was purified, and the effect of 
different protease inhibitors on the activity of 




Organism and culture conditions 
 
The isolates of Ganoderma lucidum were 
collected from different ecological niches of 
Southern India and the pure cultures were 
prepared and maintained in potato dextrose 
agar medium (PDA). All the isolates were 
screened for the production of fibrinolytic 
protease by growing them on the fibrin salt 
basal medium as optimized by Tharwat [9]. 
The medium consisted of the following 
components (g/L): fibrin, 2; NH4NO3, 0.05; 
KHPO4, 1.0 and (NH4)2SO4, 0.5. The pH of 
the medium was adjusted to 6.5 at 35 ºC and 
the isolates grown on it for 24 days under 
stationary conditions. 
 
Assay for fibrinolytic protease activity 
 
Fibrinolytic protease activity was performed 
according to the method of Greenberg [10]. 
The reaction mixture contained 8 mg bovine 
fibrin, 500 µl mycelial extract made in 
phosphate buffer, (0.05 M, pH.6.8) in a total 
volume of 1 mL. The mixture was incubated 
for 30 min at 37 °C in a water bath and 
stopped by adding 0.5 mL of 15 % cold 
trichloroacetic acid (TCA) in glass-distilled 
water. The mixture was centrifuged at 3,000 
g for 10 min to remove precipitated fibrin. To 
0.5 mL of acid soluble filtrate, 2.5 mL of 0.3M 
sodium hydroxide and 2.9 %w/v sodium 
carbonate in glass-distilled water was added, 
followed by 0.75 mL of Folin’s phenol reagent 
(diluted 1:3 with glass-distilled water). The 
mixture was incubated for 25 min at room 
temperature and the color developed was 
read at 650 nm. The heat-killed enzyme with 
fibrin substrate was used as the blank. One 
unit of enzyme activity was calculated as the 
amount of enzyme which released 1 µmol of 
tyrosine/min under the reaction conditions. 
 
Purification of fibrinolytic enzyme 
 
Unless and otherwise mentioned, all the 
purification procedures were carried out at 4 
°C. Protein concentrations were determined 
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by the method of Bradford [11]. The 
mycelium grown on modified Czapek’s dox 
broth with fibrin (MCDBF) medium was 
collected by filtering through several layers of 
cheese cloth. The mycelial mat was washed 
with 300 mL of Tris-HCl buffer (0.05 M, pH 
7.4) twice and frozen at -40 ºC. Five hundred 
grams of frozen mycelia were thawed and 
homogenized with a mortar and pestle with 
equal volume of Tris-HCl buffer (10 mM, pH 
7.4). The homogenate was collected and 
centrifuged at 10,000 g for 30 min in a 
refrigerated centrifuge (Beckman Inc, USA). 
The supernatant was collected in a sterile 
container and the proteins were precipitated 
with different saturations of ammonium 
sulphate. The precipitated proteins were 
collected by dissolving in 10 mL of Tris-HCl 
buffer (10 mM; pH 7.4) and dialyzed against 
same buffer for 48 h at 4 °C. The dialyzed 
fraction was centrifuged at 12,000 g for 10 
min to remove the insoluble materials. The 
clear supernatant collected was concentrated 
by lyophilization and stored at -20 °C until 
further use.   
 
Purification of the enzyme was performed 
first with anion exchange chromatography 
column. For this, DEAE cellulose powder (7.0 
g) was suspended in 100 mL of distilled water 
for 1 h.  The fine particles floating on the 
surface were removed and the remainder 
was washed several times with 1M NaOH 
and finally washed with glass-distilled water. 
The activated ion exchanger was packed in a 
glass column (2 × 3 cm), thoroughly washed 
with glass-distilled water and equilibrated with 
Tris-HCl buffer (20 mM; pH 7.4). The proteins 
were adsorbed on to the column and the 
unbound proteins were washed with Tris-HCl 
buffer (20 mM; pH 7.4). The column bound 
proteins were eluted with the above buffer 
with a gradient of NaCl (0 to 1.0 M).  Protein 
fractions (3.0 ml each) were collected using 
an automatic fraction collector (LKB Broma 
7000 ultra fraction collector). A total number 
of 50 fractions were collected and they were 
immediately assayed for fibrinolytic protease 
activity as described above. The enzyme 
active fractions were pooled together, 
concentrated by lyophilization and the extent 
of purity was checked on SDS-PAGE after 
silver staining. We observed that there were 
some contaminating proteins along with the 
enzyme of interest and therefore the enzyme 
had to be purified using Sephadex G-150 
column (2 × 100 cm) chromatorgraphy. A 
total of 100 fractions (5 ml each) were 
collected and each of them was assayed for 
fibrinolytic protease activity as described 
above. The enzyme-active fractions were 
pooled, concentrated and their purity again 
checked on SDS-PAGE.  
 
Effect of various metal ions on the activity 
of purified fibrinolytic protease  
 
The effect of metal ions such as MgCl2, 
ZnCl2, CoCl2, FeCl2, CaCl2 and CuSO4 on the 
enzyme activity was studied. The purified 
protease (10 µg/mL in 20 mM Tris-HCL 














ions with a final concentration of 1 
mM in 50 mM Tris-HCL buffer, pH 7.2 for 1 h 
at 37 °C and the residual activity was 
measured with 1 % casein as per the assay 
method described above.  
 
Effect of various enzyme inhibitors on 
purified fibrinolytic protease activity  
 
Two milliliters of the purified protease 
enzyme at 5 µg/mL was pre-incubated with 
an equal volume of enzyme inhibitors such as 
PMSF, Leupetin,  1, 10-phenanthroline, 
TLCK,  TPCK, EDTA and APMSF at two 
different concentrations i.e., 1 mM and 5 mM 
at 37 °C for 1 h. The residual protease 
activity was measured with 1 % casein using 
the assay method as described above.   
 
SDS-PAGE analysis for fibrinogenolytic 
activity of purified protease after 
treatment with enzyme inhibitors  
 
The purified protease (10 µg/mL) enzyme 
was treated with different enzyme inhibitors 
like EDTA, 1,10-phenanthroline, PMSF, 
TLCK, phosphoamidon and cysteine at a final 
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concentration of 5 mM for 1 h at 37ºC.  
Bovine fibrinogen, the substrate, (150 µL, 1 
g/L) was added to it and incubated for a 
further 1 h. The reaction mixtures were 
subjected to electrophoresis on SDS-PAGE 
(12 %w/v). The gel was stained with 
coomassie brilliant blue R-250 and examined 
for hydrolytic activity of the substrate.  
 
Effect of metal ions on the reactivation of 
inhibitors treated protease  
 
The purified protease (10 µg/mL) was 
incubated with EDTA at a final concentration 
of 5 mM   at 37 
o
C for 1 h. Thereafter, MgCl2, 
CaCl2 and ZnCl2 were added to the mixture at 
a final concentration 5 mM and the mixture 
was incubated for 1 h further. The substrate 
bovine fibrinogen (450 µL, 1g/L) was added 
to the reaction mixture and incubated further 
for 1 h at 37 
o
C. The entire reaction mixture 
was loaded into the wells of SDS-PAGE and 
the protein separation was carried out. The 
proteins were stained with coomassie brilliant 
blue R-250 overnight and the gel was 
examined after destaining. A similar 
experiment with 1, 10-phenanthroline (5 mM) 
instead of EDTA was also performed to study 




All data are presented as mean ± standard 
error of mean (SEM). Analysis of variance 
was performed by using SPSS (SPSS Inc., 
USA). Duncan’s new multiple range test was 
used to determine the difference of means 





Purification of fibrinolytic enzyme 
 
The intracellular fibrinolytic protease enzyme 
isolated from the mycelia mat and purified is 
listed in Table 1. The proteins precipitated 
with ammonium sulfate at 80 % saturation 
showed relatively higher protease activity 
than the proteins obtained with 30 and 60 % 
saturation . Therefore, the proteins obtained 
with 80 % saturation were used for further 
purification on DEAE-cellulose anion 
exchange column.  
 
As shown in Table 1, 12 mg enzyme was 
purified at 14.4-fold from 500 g of G. lucidum 
mycelium, with a yield of 44.6 %. The purity 
of the enzyme was checked on SDS-PAGE 
after silver nitrate staining. As shown in Fig 1 
(lane 4), the enzyme appeared homogenous. 
The molecular mass of the fibrinolytic 
enzyme was 33 kDa. 
 
Effect of different metal ions on purified 
fibrinolytic protease of G. lucidum 
 
The enzyme incubated with copper sulfate 
lost its complete activity even at 1 mM 
concentration followed by CoCl2 and FeCl2 to 
the extent of 23.6 and 84.3 % respectively, at 
1 mM concentration (Table 2). The inhibitory 
effect of CoCl2 is more pronounced when the 
concentration is increased to 5 mM from 1  
 















Homogenate 175 61,250 350 1 100 
Ammonium sulphate 
precipitation (Fraction-3) 
55 48,180 876 3.1 78.6 
DEAE-cellulose, Anion 
Exchange Chromatography 
22 36,452 1656.9 7.9 59.5 
Sephadex G-150 column 
Chromotography 
12 27,350 2279.1 14.5 44.6 
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Figure 1: Molecular mass determination of purified 
fibrinolytic protease on SDS-PAGE under reducing 
conditions 
Lanes: M =  Protein molecular weight standards;  1 = 
Crude enzyme;  2 = Ammonium sulphate precipitated 
protein fraction-3; 3 = DEAE-cellulose column eluted 
proteins; 4 = Sephadex G-150 column eluted protein. 
(Protein molecular mass standards: 97 
kDa:phosphorylase; 66 kDa: bovine serum albumin; 45 
kDa: ovalbumin; 30 kDa: carbonic anhydrase; 20.1 kDa: 
soybean inhibitor and 14.4kDa: α-lactalbumin).   
 
mM. On the other hand metal ions such as 
CaCl2, MgCl2 and ZnCl2 enhanced the 
enzyme activity and the activity increase 
observed was 35.2, 18.3 and 8.3 %, 
respectively, at 1 mM concentration. There 
was a decrease in the enhancement of the 
enzyme activity when the concentration of 
CaCl2 increased from 1mM to 5 mM. 
 
Effect of different inhibitors on purified 
fibrinolytic protease of G. lucidum  
 
The purified enzyme lost its complete activity 
when the enzyme was incubated with 1, 10-
phenonthroline, EDTA and phosphoamidon 
at a final concentration of 5 mM (Table 2). 
TLCK inhibited the enzyme to a lesser extent 
(13.7 %). Protease inhibitors such as 
leupeptin, PMSF, TPCK and APMSF did not 
inhibit the enzyme activity but there were 
marginal increase in enzyme activity in these 
cases when compared to the control (Table 
2). 
 
SDS-PAGE analysis for fibrinogenolytic 
activity of purified protease after 
treatment with enzyme inhibitors  
 
As shown in Fig 2, the enzyme incubated 
with EDTA, 1, 10-phenanthroline, 
phosphoamidon and cysteine (lanes 2, 3, 6 
and 7) did not hydrolyze the substrate and 
appeared intact as that of the control (lane F); 
this indicates complete inactivation of the 
enzyme by the inhibitors. As is evident from 
Fig 2 (lanes 4 and 5), the enzyme treated 
with PMSF and TLCK hydrolyzed the 
substrate, indicating the inability of these 
inhibitors to inhibit the enzyme activity. 
 
Table 2: Effect of protease inhibitors on purified 
fibrinolytic protease of G. lucidum 
 
Residual protease activity 
(%) Metal ion 
1 mM 5 mM 
Control 100±100 100±100 
ZnCl2 108.3±13.0 98.0±9.8 
MgCl2 118.3±14.2 102.0±9.2 
FeCl2 85.7±9.4 81.0±9.7 
CuSO4 No activity No activity 
CoCl2 76.4±9.9 16.0±1.6 
CaCl2 135.2±16.2 125.0±16.3 
PMSF - 102±12.2 
PT - No activity 
TLCK - 86.3±7.8 
TPCK - 101.0±9.1 
EDTA - No activity 
APMSF - 107.0±8.6 
PP - No activity 
*Leupeptin - 104.0±11.4 
• 2mM final concentration; PT = 1,10-
phenanthroline; PP = phosphoamidon, EDTA = 
Ethylene dimethyl trichloro aectic acid: PMSF = 
phenylmethyl sulfonyl fluoride: AMPSF = amdino 
phenylmethyl sulfonyl fluoride: TLCK = Tosyl-L-lysine 





Kumaran et al  
Trop J Pharm Res, August 2011;10 (4): 418 
 
Figure 2: SDS-PAGE analysis of fibrinogenolytic 
activity of purified fibrinolytic protease after 
treatment with protease inhibitors  
Lanes: F = Fibrinogen; 1 = Protease + fibrinogen;  2 = 
Protease + 5mM EDTA + fibrinogen; 3 = Protease + 5 
mM 1,10-phenanthroline + fibrinogen; 4 = Protease + 5 
mM PMSF + fibrinogen;  5 = Protease + 5 mM TLCK + 
fibrinogen; 6 = Protease + 5 mM phosphoamidon + 
fibrinogen; 7 = Protease + 5mM cysteine + fibrinogen 
 
 
Effect of metal ions on the reactivation of 
inhibitor-treated protease  
 
In order to verify if the enzyme inhibition by 
EDTA, 1, 10-phenanthroline, phosphoamidon 
and cysteine as observed above (Fig 2) is 
permanent or the activity could be restored 
by metal ions, the inhibited enzyme was 
treated with metal ions. As shown in Fig 3, 
addition of ZnCl2, MgCl2 and CaCl2 to the 
enzyme treated with EDTA reactivated 
enzyme activity (Fig 3: lanes 3, 4 and 5). 
Similarly the enzyme inhibition by 1, 10- 
phenanthroline was restored by the addition 




Figure 3: SDS-PAGE analysis of enzyme 
reactivation by metal ions after treatment with 
enzyme inhibitors  
Lanes: F = Fibrinogen; 1 = Protease +fibrinogen; 2 = 
Protease +1mM  EDTA+fibrinogen;  3 = 
Protease+1mMEDTA+ZnCl2+fibrinogen; 4=Protease 
+1mM  EDTA+MgCl2+fibrinogen;  5= Protease +1mM  
EDTA+CaCl2+fibrinogen; 6 = Protease +1mM 1,10-
phenanthroline +fibrinogen; 7 = Protease +1mM 1,10-
phenanthroline+1mM CaCl2+fibrinogen; 8 = Protease 
+1mM 1,10-phenanthroline+5mM CaCl2+fibrinogen 
 
DISCUSSION                                                       
 
An attempt has been made in the present 
study to evaluate the inhibitory activity of 
different metal ions and some commercial 
protease inhibitors on the activity of an 
intracellular fibrinolytic protease isolated and 
purified from the mycelium of G. lucidum. As 
seen in Fig. 1, lane 4, the purified enzyme 
appeared as a single homogenous band on 
SDS-PAGE after silver nitrate staining and 
the purity of the enzyme was thus confirmed. 
The molecular mass of the purified enzyme 
was 33.2 kDa. The fibrinolytic proteases 
isolated from the culture filtrates of 
Aspergillus fumigatus, 33 kDa [12], exactly 
correspond to the molecular mass of 
fibrinolytic protease purified from G. lucidum 
in this study.  
 
CuSO4 completely inactivated the enzyme at 
all the concentrations tested followed by 
CoCl2 which inhibited the enzyme activity to 
the extent of 23 and 84 % at 1 and 5 mM 
concentrations, respectively, compared with 
control. On the other hand, addition of CaCl2, 
MgCl2 and ZnCl2 to the enzyme enhanced 
activity and the enhancement was more 
pronounced with CaCl2. A fibrinolytic 
protease isolated from Tenodera sinensis has 
been shown to be sensitive to CuSO4 and its 
activity was enhanced when the enzyme was 







 [13].  
 
Lee et al. [14] have found that the fibrinolytic 





, but enhanced by 




 ions. In 
contrast, the fibrinolytic proteases isolated 
from B. subtilis and B. polymxa were not 
inhibited by Cu
2+
 [15], whereas the fibrinolytic 
proteases of Aspergillus ochraceus HP-19 
were completely resistant to the action of 
heavy metals, and their activities were 
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stabilized by the addition of Ca
2+
 ion [16]. The 
activity of fibrinolytic protease was recovered 











 [17]. The 
protease of Oidiodendron flavum has been 





, but was inhibited by Co
2+





The purified fibrinolytic protease of G. 
lucidum was highly sensitive to EDTA, 1, 10-
phenanthroline and phosphoamidon and 
insensitive to leupeptin, PMSF, TPCK, and 
APMSF. The sensitivity of the purified 
protease to EDTA clearly shows that it could 
be a metalloprotease. A similar observation 
had been made by some authors previously 
[14] with the same organism; however, the 
molecular mass of the enzyme was estimated 
to be 54 kDa, which clearly indicates that the 
enzyme purified in this study is different from 
the one reported earlier.  The fibrinolytic 
proteases of the wild mushroom, Tricholoma 
saponaceum, and the cultivated Pleurotus 
ostreatus were sensitive to EDTA and 1, 10 
phenanthroline [18].  Most of the α-
fibrinogenases found in snake venom are 
metalloproteinases and they are sensitive to 
the action of EDTA [19]. The 
metalloproteinase nature of fibrolase has 
been confirmed by the observation that 
fibrolase activity is completely and rapidly 
inhibited by the addition of EDTA and 1,10-




The results obtained in the present study 
clearly show that copper sulfate completely 







ions enhanced the activity. The 
purified protease was very sensitive to 
protease inhibitors such as EDTA, 1, 10-
phenanthroline and phosphoamidon which 
inhibited the enzyme completely and 
insensitive to TPCK, leupeptin, PMSF, and 
APMSF. The sensitivity of this enzyme to 
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